Molecular Mechanisms, Drug discovery, Clinical research, Epidemiology, PTSD, schizophrenia, MDD, E Alzheimer disease, Stroke, Aging, Cotinine, Caffeine, antioxidants, Nicotinic acetylcholine receptors, Astrocytes, Ethnopharmacology.

2006-2023
- PhD Thesis
1. Cristhian Mendoza)(2018). Docente Investigador. USS
2. Alex Grizzell) Co-tutor (University of South Florida), Prof. Assistant Professor
3. Rafael Vides, MD, Psychiatrist. 2023. (Universidad de San Carlos de Guatemala
Facultad de Ciencias Médicas. Escuela de Estudios de Postgrado

Master Thesis
- Magister BMENT
1. Ms. Nathalie Alvarez Ricartes TM, MS.(2023). (Lecturer de TM.USS)
2. Ms. Patricia Olivares Matus, TM. Pending. (TM Clinical Laboratory, Pto. Montt)
3. Mr. Nelson Perez Urrutia.TM. Pending. ( Lecturer. USSs)

Master in Biomedicine (University of South Florida) (9 graduates)
4. Sagar Patel. (2014). MD Emergency.
5. Rosalyn Solomon NP(2014). Nurse Practitioner.
6. John Tran J. NP (2014). Nurse
7. Rosaly Holmes (2014).
8. Michelle Mullins M .(2014). (Scientist Florida Department of Law Enforcement-Biology/DNA)
9. Rohani A .(2014). MD.
10. Leila Charry .(2014). MD.

Undergraduate Thesis
- Students of Medical Technology (TM),
1. Carlos Silva Lavin (2016-1)(EB)
2. Nelson Perez Urrutia (2016-2)
3. Patricia Oliveros Matus (2016-2)
4. Francisco Susperreguy Montoya (2018-1)
5. John Hernandez Escanilla (2018-1)
6. Luis Hidalgo (2018-2)
7. Genesis (2018-2)
8. Gloria Cárdenas Véliz (2018-2)
9. Nathalie Diaz Sanhueza (2019-2)
10. Nicolás Ignacio Maldonado Pino (2021-2)
11. Danitza Guzman Fernandez (2021-2)
12. Pablo Toro (2021-2)
13. Miriam Cornejo (2021-2)
14. Nataly Arriasa Leiva (2021-2)
15. Javiera Alvarez (2022-1)
16. Thiare Rosales (2022-1)
17. Alberto Lopez (2023-1)
-Florida State University, 2007
Undergraduate BS-Biology Thesis
18. Sarah Burgess, (). BS. NP. Veterans Affairs Administration.

EDITORIAL BOARDS

American Journal of Alzheimer's Disease and Other Dementias; Journal of Alzheimer's Disease Associate Editor); Frontiers in ethnopharmacology; Neural Regeneration Research; World Journal of Pharmacology, Behavioral sciences; Frontiers in Pharmacology;American Journal of Neurodegenerative Disease; International Neuropsychiatric Disease Journal; Chronic Diseases – International; SM Journal of Depression Research and Treatment; Encyclopedia (Oxford).
Editor (>15 peer-reviewed journals); Ad Hoc Reviewer (33 journals).

Associate Editor Frontiers in Ethnopharmacology; Clinical Neurosciences; Guest Associate Editor: Front in Aging Neuroscience Archive, Neurodegeneration; Molecular Signalling and Pathways; Cellular and Molecular Mechanisms of Brain-aging; Alzheimer's Disease and Related Dementias; Review Editor Front in Aging Neuroscience Archive; Neurotrauma; Cellular and Molecular Mechanisms of Brain-aging; Psychiatry.

Patents

1. US 9,801,865 B2 Materials and methods for diagnosing, preventing, and treating stress disorders and conditions associated with Abeta peptide aggregation. The subject of the invention concerns treating posttraumatic stress disorder. Inventor: Valentina Echeverria Moran (United States of America (USA) Department of Veterans Affairs (VA), University of South Florida (USF), filed Sep. 24, 2009. Approved: October 31, 2017.
2. US 10238641 B2. The subject invention concerns using Cotinine to detect the accumulation of Amyloid beta peptide in neural tissue and diagnose conditions such as AD. The method comprises administering Cotinine labeled with a radioisotope to a person or animal to be detected by Positron Emission Tomography (PET). Filed: October 4, 2017. Date of Patent: March 26, 2019. Assignees: USF, and the USA represented by the VA. Inventor: Valentina Echeverria Moran.
3. US 10, 307,411 B2 The Use of Cotinine in Treating or Preventing Neurogenesis Deficits and Enhancing Neurogenesis. The subject invention concerns methods for preventing neurogenesis deficits in neural tissue in a human or Animal. Inventor:Valentina Echeverria Moran & Doreen Appunn (VA Filed 1/5/2017. Approved; June 4, 2019.
4. US 2020/0000790 A1 The combination of Cotinine plus antioxidants for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other brain Conditions. Appl. No: 16/486,498 (22). PCT Filed: February 16, 2018 (86) PCT No .: PCT/IB18 / 00306 § 371 (c) (1)(2 Aug. 15, 2019. 16-02-2018. Expiration date:16-02-2038.
5. Chile. 2019-2313, registration: 64.986. Submitted 14-08-2019, Granted 20-05-2022. Date of registration in Chile. 01-08-2022.Uso de cotinina y Aceite de krill para tratar o prevenir un trastorno inducido por estrés crónico, (depresión o ansiedad) y composición farmacéutica que los comprende, Universidad San Sebastián, The USA as represented by the VA. Chile, by the Instituto Nacional de Propiedad Industrial. Santiago, 22 de Agosto de 2022. 9:41:06. Expiration date:16-02-2038.
6. USA-Chile. US Patent No. 63/551,952 titled “Use of Cotinine to Reduce the Ill Effects of Stress in Farmed Sea Animals”. filed February 9, 2024 (VA ID No. 2017-449-06)